Key result
GINST and compound K decrease hepatocyte cholesterol synthesis by reducing HMG-CoA reductase via AMPKα activation.
Why the study?
Hypercholesterolemia leads to atherosclerosis and coronary heart disease, and the effects of GINST and its metabolite IH-901 on cholesterol synthesis and related pathways in liver cells were unclear.
Does GINST reduce cholesterol synthesis in HepG2 cells?
Does GINST reduce cholesterol synthesis in HepG2 cells?
GINST and its metabolite compound K inhibit cholesterol synthesis in liver cells by decreasing HMGCR expression via AMPKα activation, suggesting potential utility in reducing hypercholesterolemia.
Answers are grounded in this paper and cite their sources.
No clinical use indicated from cell data; leaves open in vivo lipid effects of GINST via AMPKα.
GINST, a hydrolyzed ginseng extract, has been reported to have antidiabetic effects and to reduce hyperglycemia and hyperlipidemia. Hypercholesterolemia is caused by diet or genetic factors and can lead to atherosclerosis and coronary heart disease. Thus, the purpose of this study is to determine whether GINST and the ginsenoside metabolite, IH-901 (compound K), reduce cholesterol synthesis in HepG2 cells and the signal transduction pathways involved. Concentrations of cholesterol were measured by using an enzymatic method. Expression levels of sterol regulatory element-binding protein 2 (SREBP2), HMG-CoA reductase (HMGCR), peroxisome proliferators-activated receptor γ (PPARγ), CCAAT/enhancer-binding proteins α (C/EBPα), GAPDH, and phosphorylation of AMP-activated protein kinase α (AMPKα), protein kinase B (PKB, also known as Akt), and mechanistic target of rapamycin complex 1 (mTORC1) were measured using western blot. Total cholesterol concentration decreased after GINST treatment for 24 and 48 h. Expression of HMGCR decreased more with GINST than with the inhibitors, U18666A and atorvastatin, after 48 h in a dose-dependent manner. Phosphorylation of AMPKα increased 2.5x by GINST after 360 min of treatment, and phosphorylation of Akt decreased after 120 and 360 min. We separated compound K from GINST extracts flash chromatography. Compound K decreased cholesterol synthesis in HepG2 cells at 24 and 48 h. Therefore, we conclude that GINST inhibits cholesterol synthesis in HepG2 cells by decreasing HMGCR expression via AMPKα activation. PRACTICAL APPLICATION: GINST, a hydrolyzed ginseng extract, can inhibit cholesterol synthesis in liver cells via activation of AMPKα. IH-901 (compound K), which is the main component with bioactivity in GINST, also has anticholesterol effects. Thus, we suggest that GINST can be used to reduce hypercholesterolemia.
No takes yet. Share an insight, caveat, or question.
Han et al. (2017) studied Hypercholesterolemia. GINST (hydrolyzed ginseng extract) and IH-901 (compound K) vs. U18666A and atorvastatin was evaluated on Total cholesterol concentration and HMGCR expression. GINST and its metabolite compound K decreased cholesterol synthesis in HepG2 cells by reducing HMG-CoA reductase expression via AMPKα activation.
Synapse has enriched 10 related papers. Consider them for comparative context: